2,6-Disubstituted quinazolines, quinoxalines, quinolines and isoquinolines and methods of their use as inhibitors of RAF kinase
2 Assignments
0 Petitions
Accused Products
Abstract
New substituted quinazoline, quinoxaline, quinoline and isoquinoline compounds, compositions and methods of inhibition of Raf kinase activity in a human or animal subject are provided. The new compounds compositions may be used either alone or in combination with at least one additional agent for the treatment of a Raf kinase mediated disorder, such as cancer.
36 Citations
93 Claims
- 1. A compound of the formula (I):
-
15. A compound of claim 15 wherein R3 is methoxy.
- 21. A compound of the formula (II):
- 40. A compound of the formula (III):
- 59. A compound of the formula (IV):
Specification